In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua

Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

After her husband's diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.

by Miriam Díaz-Gilbert

Forward Look

Some rectal cancer patients may safely avoid life-altering surgery.

by Kristine Conner

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey

Healthy Habits

Aspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.

by Bradley Jones

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett

New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

by Anna Goshua

Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

by Judy Pearson